Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
| Plasmid Name | Proper Citation | Insert Name | Organism | Bacterial Resistance | Defining Citation |
Comments |
||||
|---|---|---|---|---|---|---|---|---|---|---|
|
pJL2-mGold-P2A-EBFP2 Resource Report Resource Website |
RRID:Addgene_157998 | mGold-P2A-EBFP2 | Synthetic | Ampicillin | PMID:33097540 | A mammalian expression cassette was cloned into a yeast vector. mGold: FPBaseID TBD EBFP2: FPBaseID DVMQ7 Please note that the mVenus annotation in the plasmid map is incorrect, as this plasmid encodes mGold. | Backbone Size:6992; Vector Backbone:pJL2; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | mGold is mVenus with L46F;T63S mutations | 2026-09-19 02:11:46 | 0 |
|
pJL-mGold Resource Report Resource Website |
RRID:Addgene_157997 | mGold | Synthetic | Ampicillin | PMID:33097540 | Please note that the mVenus annotation in the plasmid map is incorrect, as this plasmid encodes mGold. | Backbone Size:6950; Vector Backbone:pJL; Vector Types:Yeast Expression; Bacterial Resistance:Ampicillin | mGold is mVenus with L46F;T63S mutations | 2026-09-19 02:11:46 | 0 |
|
pSFFV_CloGFP(1-10) Resource Report Resource Website |
RRID:Addgene_157994 | CloGFP(1-10) | Synthetic | Ampicillin | PMID:33227014 | Backbone Size:9000; Vector Backbone:pHR-SFFV; Vector Types:Mammalian Expression, Lentiviral; Bacterial Resistance:Ampicillin | G32Q, F46L, K101R, S202L | 2026-09-19 02:11:46 | 0 | |
|
pSFFV_mNG3K(1-10) Resource Report Resource Website 1+ mentions |
RRID:Addgene_157993 | pSFFV_mNG3K(1-10) | Synthetic | Ampicillin | PMID:33227014 | Backbone Size:9000; Vector Backbone:pHR-SFFV; Vector Types:Mammalian Expression, Lentiviral; Bacterial Resistance:Ampicillin | G27D, D42E, M128I, K153M, T170I | 2026-09-19 02:11:46 | 2 | |
|
pCaggs-mGold Resource Report Resource Website 1+ mentions |
RRID:Addgene_157996 | mGold | Synthetic | Ampicillin | PMID:33097540 | Please note that the mVenus annotation in the plasmid map is incorrect, as this plasmid encodes mGold. | Backbone Size:6105; Vector Backbone:pCaggs; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | mGold is mVenus with L46F;T63S mutations | 2026-09-19 02:11:46 | 1 |
|
pVL1393-MAL-SYK Resource Report Resource Website |
RRID:Addgene_157990 | Spleen tyrosine kinase | Homo sapiens | Ampicillin | PMID:29890824 | Vector Backbone:pVL1393; Vector Types:Insect Expression; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:46 | 0 | ||
|
pLKO-CreERT2 sgAdam10 v3 Resource Report Resource Website |
RRID:Addgene_158047 | Adam10 sgRNA | Mus musculus | Ampicillin | PMID:32165588 | Vector Backbone:pLKO-ERT2 Cre stuffer v3; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:47 | 0 | ||
|
pBS-GMR-eya(shRNA) Resource Report Resource Website 1+ mentions |
RRID:Addgene_157991 | Ampicillin | PMID:33016195 | Backbone Size:2961; Vector Backbone:pBSII-KS(-); Vector Types:CRISPR; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:46 | 3 | ||||
|
pDOC-K-glmS-GFPrev Resource Report Resource Website |
RRID:Addgene_158060 | Green Fluorescent Protein optimised for excitation with UV light | Synthetic | Ampicillin | PMID:33226934 | Backbone Marker:Addgene #158058; Backbone Size:8079; Vector Backbone:pDOC-K-glmS; Vector Types:Bacterial Expression, Synthetic Biology; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:47 | 0 | ||
|
pDOC-K-glmS-lacIZ Resource Report Resource Website |
RRID:Addgene_158061 | lacIZ operon | Escherichia coli | Ampicillin | PMID:33226934 | Backbone Marker:Addgene #158058; Backbone Size:8079; Vector Backbone:pDOC-K-glmS; Vector Types:Bacterial Expression, Synthetic Biology; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:47 | 0 | ||
|
pDOC-K-glmS Resource Report Resource Website |
RRID:Addgene_158058 | glmS homologous region 1 | Salmonella enterica Ser. Typhimurium | Ampicillin | PMID:33226934 | Backbone Size:7233; Vector Backbone:pDOC-K; Vector Types:Synthetic Biology; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:47 | 0 | ||
|
p667-UBC-PHKG1-V5-miniTurbo_IDG-K Resource Report Resource Website |
RRID:Addgene_158192 | PHKG1-V5-miniTurbo | Homo sapiens | Ampicillin | These plasmids were generated as part of the Illuminating the Druggable Genome (IDG) program sponsored by the NIH Common Fund. The goal of this program is to identify, gather, and distribute information and resources for proteins that currently are not well-studied yet belong to commonly drug-targeted protein families: protein kinases, non-olfactory G-protein coupled receptors (GPCRs), and ion channels. The IDG program is designed to develop fundamental research tools for understudied proteins, elucidate their function, and disseminate the IDG-related resources and data to the greater scientific community. These lentiviral gateway destination plasmids were generated, as part of the Kinase-Data and Resource Generating Center (DRGC), using the single fragment or multisite gateway cloning technology. They were used for generating proteomics-based protein-interaction and protein-proximity networks that can be accessed through the kinase-DRGC website https://darkkinome.org/. Each plasmid has either an N- or C-terminal fusion protein (Flag/ V5/V5-miniTurbo/V5-TurboID/miniTurbo-V5/TurboID-V5) tagged understudied kinase driven under either a CMV or Ubiquitin (UBC) promoter. All inserts in the pENTR plasmids used to generate the deposited destination plasmids were end-sequenced and insert size validated prior to multi-site gateway cloning. The combined insert size of the single fragment or three fragment destination plasmids were confirmed by restriction digestion (BsrGI, and EcoRV for pDest667; BsrGI, EcoRV, and BstZ17I for pDest663; and BsrGI for pHAGE) and all plasmids were partially sequenced to ensure in-frame ORFs and fusion tags. | Backbone Marker:PEL; Backbone Size:9014; Vector Backbone:pDest667; Vector Types:Mammalian Expression, Lentiviral, Gateway Destination; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:49 | 0 | ||
|
p667-UBC-DYRK3-V5-miniTurbo_IDG-K Resource Report Resource Website |
RRID:Addgene_158190 | DYRK3-V5-miniTurbo | Homo sapiens | Ampicillin | Depositor confirms R293H does not affect plasmid function. This is a known sequence conflict. These plasmids were generated as part of the Illuminating the Druggable Genome (IDG) program sponsored by the NIH Common Fund. The goal of this program is to identify, gather, and distribute information and resources for proteins that currently are not well-studied yet belong to commonly drug-targeted protein families: protein kinases, non-olfactory G-protein coupled receptors (GPCRs), and ion channels. The IDG program is designed to develop fundamental research tools for understudied proteins, elucidate their function, and disseminate the IDG-related resources and data to the greater scientific community. These lentiviral gateway destination plasmids were generated, as part of the Kinase-Data and Resource Generating Center (DRGC), using the single fragment or multisite gateway cloning technology. They were used for generating proteomics-based protein-interaction and protein-proximity networks that can be accessed through the kinase-DRGC website https://darkkinome.org/. Each plasmid has either an N- or C-terminal fusion protein (Flag/ V5/V5-miniTurbo/V5-TurboID/miniTurbo-V5/TurboID-V5) tagged understudied kinase driven under either a CMV or Ubiquitin (UBC) promoter. All inserts in the pENTR plasmids used to generate the deposited destination plasmids were end-sequenced and insert size validated prior to multi-site gateway cloning. The combined insert size of the single fragment or three fragment destination plasmids were confirmed by restriction digestion (BsrGI, and EcoRV for pDest667; BsrGI, EcoRV, and BstZ17I for pDest663; and BsrGI for pHAGE) and all plasmids were partially sequenced to ensure in-frame ORFs and fusion tags. | Backbone Marker:PEL; Backbone Size:9014; Vector Backbone:pDest667; Vector Types:Mammalian Expression, Lentiviral, Gateway Destination; Bacterial Resistance:Ampicillin | R293H- please see depositor comments | 2026-09-19 02:11:49 | 0 | |
|
pJWK_VD_02 Resource Report Resource Website |
RRID:Addgene_158103 | 5'UTR synthetic stem-loop -30kcal/mol | Synthetic | Ampicillin | PMID:32846140 | Backbone Marker:Promega; Backbone Size:4716; Vector Backbone:pGL4.53(luc2/PGK); Vector Types:Mammalian Expression, Luciferase; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:48 | 0 | ||
|
pJWK_VD_03 Resource Report Resource Website |
RRID:Addgene_158104 | 5'UTR of CACNA1C (uc009zdu.1) | Homo sapiens | Ampicillin | PMID:32846140 | Backbone Marker:Promega; Backbone Size:4716; Vector Backbone:pGL4.53(luc2/PGK); Vector Types:Mammalian Expression, Luciferase; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:48 | 0 | ||
|
p667-UBC-BCKDK-V5-miniTurbo_IDG-K Resource Report Resource Website |
RRID:Addgene_158189 | BCKDK-V5-miniTurbo | Homo sapiens | Ampicillin | These plasmids were generated as part of the Illuminating the Druggable Genome (IDG) program sponsored by the NIH Common Fund. The goal of this program is to identify, gather, and distribute information and resources for proteins that currently are not well-studied yet belong to commonly drug-targeted protein families: protein kinases, non-olfactory G-protein coupled receptors (GPCRs), and ion channels. The IDG program is designed to develop fundamental research tools for understudied proteins, elucidate their function, and disseminate the IDG-related resources and data to the greater scientific community. These lentiviral gateway destination plasmids were generated, as part of the Kinase-Data and Resource Generating Center (DRGC), using the single fragment or multisite gateway cloning technology. They were used for generating proteomics-based protein-interaction and protein-proximity networks that can be accessed through the kinase-DRGC website https://darkkinome.org/. Each plasmid has either an N- or C-terminal fusion protein (Flag/ V5/V5-miniTurbo/V5-TurboID/miniTurbo-V5/TurboID-V5) tagged understudied kinase driven under either a CMV or Ubiquitin (UBC) promoter. All inserts in the pENTR plasmids used to generate the deposited destination plasmids were end-sequenced and insert size validated prior to multi-site gateway cloning. The combined insert size of the single fragment or three fragment destination plasmids were confirmed by restriction digestion (BsrGI, and EcoRV for pDest667; BsrGI, EcoRV, and BstZ17I for pDest663; and BsrGI for pHAGE) and all plasmids were partially sequenced to ensure in-frame ORFs and fusion tags. | Backbone Marker:PEL; Backbone Size:9014; Vector Backbone:pDest667; Vector Types:Mammalian Expression, Lentiviral, Gateway Destination; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:49 | 0 | ||
|
pJWK_VD_01 Resource Report Resource Website |
RRID:Addgene_158102 | 5'UTR synthetic stem-loop 0kcal/mol | Synthetic | Ampicillin | PMID:32846140 | Backbone Marker:Promega; Backbone Size:4716; Vector Backbone:pGL4.53(luc2/PGK); Vector Types:Mammalian Expression, Luciferase; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:48 | 0 | ||
|
p663-UBC-miniTurbo-V5-ICK_IDG-K Resource Report Resource Website |
RRID:Addgene_158187 | miniTurbo-V5-ICK | Homo sapiens | Ampicillin | These plasmids were generated as part of the Illuminating the Druggable Genome (IDG) program sponsored by the NIH Common Fund. The goal of this program is to identify, gather, and distribute information and resources for proteins that currently are not well-studied yet belong to commonly drug-targeted protein families: protein kinases, non-olfactory G-protein coupled receptors (GPCRs), and ion channels. The IDG program is designed to develop fundamental research tools for understudied proteins, elucidate their function, and disseminate the IDG-related resources and data to the greater scientific community. These lentiviral gateway destination plasmids were generated, as part of the Kinase-Data and Resource Generating Center (DRGC), using the single fragment or multisite gateway cloning technology. They were used for generating proteomics-based protein-interaction and protein-proximity networks that can be accessed through the kinase-DRGC website https://darkkinome.org/. Each plasmid has either an N- or C-terminal fusion protein (Flag/ V5/V5-miniTurbo/V5-TurboID/miniTurbo-V5/TurboID-V5) tagged understudied kinase driven under either a CMV or Ubiquitin (UBC) promoter. All inserts in the pENTR plasmids used to generate the deposited destination plasmids were end-sequenced and insert size validated prior to multi-site gateway cloning. The combined insert size of the single fragment or three fragment destination plasmids were confirmed by restriction digestion (BsrGI, and EcoRV for pDest667; BsrGI, EcoRV, and BstZ17I for pDest663; and BsrGI for pHAGE) and all plasmids were partially sequenced to ensure in-frame ORFs and fusion tags. | Backbone Marker:PEL; Backbone Size:9019; Vector Backbone:pDest663; Vector Types:Mammalian Expression, Lentiviral, Gateway Destination; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:49 | 0 | ||
|
p663-UBC-miniTurbo-V5-DYRK4_IDG-K Resource Report Resource Website |
RRID:Addgene_158184 | miniTurbo-V5-DYRK4 | Homo sapiens | Ampicillin | These plasmids were generated as part of the Illuminating the Druggable Genome (IDG) program sponsored by the NIH Common Fund. The goal of this program is to identify, gather, and distribute information and resources for proteins that currently are not well-studied yet belong to commonly drug-targeted protein families: protein kinases, non-olfactory G-protein coupled receptors (GPCRs), and ion channels. The IDG program is designed to develop fundamental research tools for understudied proteins, elucidate their function, and disseminate the IDG-related resources and data to the greater scientific community. These lentiviral gateway destination plasmids were generated, as part of the Kinase-Data and Resource Generating Center (DRGC), using the single fragment or multisite gateway cloning technology. They were used for generating proteomics-based protein-interaction and protein-proximity networks that can be accessed through the kinase-DRGC website https://darkkinome.org/. Each plasmid has either an N- or C-terminal fusion protein (Flag/ V5/V5-miniTurbo/V5-TurboID/miniTurbo-V5/TurboID-V5) tagged understudied kinase driven under either a CMV or Ubiquitin (UBC) promoter. All inserts in the pENTR plasmids used to generate the deposited destination plasmids were end-sequenced and insert size validated prior to multi-site gateway cloning. The combined insert size of the single fragment or three fragment destination plasmids were confirmed by restriction digestion (BsrGI, and EcoRV for pDest667; BsrGI, EcoRV, and BstZ17I for pDest663; and BsrGI for pHAGE) and all plasmids were partially sequenced to ensure in-frame ORFs and fusion tags. | Backbone Marker:PEL; Backbone Size:9019; Vector Backbone:pDest663; Vector Types:Mammalian Expression, Lentiviral, Gateway Destination; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:49 | 0 | ||
|
pscALPSpuro-FcACE2 (Cat) Resource Report Resource Website 1+ mentions |
RRID:Addgene_158082 | Cat ACE2 | Ampicillin | PMID:32991842 | Vector Backbone:pscALPS; Vector Types:Mammalian Expression, Lentiviral; Bacterial Resistance:Ampicillin | 2026-09-19 02:11:47 | 1 |
Can't find your Plasmid?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific plasmid, it's easier to enter an RRID or an Addgene Catalog Number to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your plasmid in the search results, please help us by registering it into the system — it's easy. Register it with Addgene.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
